with abundant small and clustered, but not aggregated crystals. Background. The aim of this study was to measure the effects of normal (nTHP) and abnormal stone former Conclusion. Citrate appears to be the main determinant of CaOx crystallization rates and crystal morpho-Tamm-Horsfall protein (SF-THP) on calcium oxalate (CaOx) nucleation and aggregation as well as on crystal logy in the presence of nTHP as well as SF-THP. Its effects appear to predominate over those of THP, since morphology, in presence or absence of citrate. Methods. Nucleation and aggregation of CaOx crys-even promotory SF-THP is turned into a crystallization inhibitor in the presence of citrate. This re-emphasizes tals from a supersaturated, stirred solution (200 mM NaCl, 10 mM Na-acetate, pH 5.70, 5 mM Ca and at a morphological level what has been concluded from functional as well from clinical studies, namely that 0.5 mM Ox) were studied by spectrophotometric timecourse measurements of OD at 620 nm (OD 620 ). citrate is needed in urine at equimolar concentrations to calcium in order to prevent the formation of large Measured parameters were induction time t I (time to induce formation of detectable particles), S N , (slope of crystal aggregates in presence of abnormal THP. increase of OD 620 , mainly due to crystal nucleation), and S A , (slope of decrease of OD 620 after equilibrium Keywords: calcium nephrolithiasis; citrate; crystal morhas been reached, due to crystal aggregation). Effects phology; hypocitraturia; inhibitors of crystallization; of citrate, nTHP and SF-THP on these parameters Tamm-Horsfall protein were measured, and scanning electron microscopy (SEM ) was performed.
was then added to obtain final concentrations of 5 mM clear that human urine contains many compounds calcium and 0.5 mM oxalate respectively. which-by adsorption to surfaces of newly formed As previously described in detail [18] , automated timeurinary crystals-alter crystal surface properties and course measurements of optical density at 620 nm (OD 620 ) thus the rates of crystal growth and aggregation [3] . were performed after addition of the calcium-containing These compounds act at concentrations much too low solution, consisting of OD 620 recordings every 12 s over to affect urinary supersaturation. Most of them are 20 min; experiments with added inhibitors, where rates of macromolecules, such as glycosaminoglycans [5] , CaOx crystal nucleation and aggregation were considerably Tamm-Horsfall glycoprotein ( THP) [6 ] , osteopontin lower, had to be extended to 40 or even 60 min. All crystal- [7] , nephrocalcin [8] , inter-a-trypsin inhibitor or bikulization experiments were performed at least in triplicate.
As depicted in Figure 1 , the time from addition of calcium nin [9,10], and urinary prothrombin fragment 1 [11] .
until the first detectable increment of OD 620 , named induction Evidence has previously been presented [12] [13] [14] that time t I , reflects the time required for CaOx crystal nuclei to normal THP (nTHP) may be a powerful inhibitor of form in numbers and grow into sizes which allow for CaOx crystal aggregation. It appears, however, that detection by turbidimetry [18] . When the slope of increase certain severely recurrent calcium renal stone formers of OD 620
with time reaches its maximum, the increase in excrete abnormal urinary THP molecules [15] which turbidity mainly reflects an increase in particle number in are weak inhibitors or even promoters of crystal function of time and thus crystal nucleation; this slope is aggregation [16 ] . The promotive effect of abnormal termed S N . As already pointed out in our previous publication stone former THP on CaOx crystal aggregation in vitro [18] and convincingly confirmed by a recent image analysis goes along with the formation of larger molecular of CaOx crystallization studies using a very similar experimental set-up [19] , increases in particle sizes, i.e. growth of particles in comparison with nTHP, i.e. increased self- We recently have developed a spectrophotometric, time can be observed ( Figure 1 ) in the continuously stirred non-seeded supersaturation decay system which allows homogeneous suspension. Since total crystal mass remains for separate, but not independent measurements of constant, the decrease in OD 620 with time must reflect a CaOx nucleation and aggregation in a single experidecline in particle number due to crystal aggregation, which ment [18] . Using this same assay system as well as indeed has been demonstrated by SEM [18] . Thus, the slope of decrease of OD 620 with time in a given experiment can be scanning electron microscopy (SEM ), we wanted to taken as a measure of crystal aggregation. This slope has a further assess differences between nTHP and abnormal negative value; for convenience−slope of decrease of OD 620 stone former THP (SF-THP) and their interaction with time, i.e. a positive number named S A , will be used for with citrate, especially with respect to CaOx crystallizaall comparisons.
tion rates and crystal morphology.
Modulators of CaOx crystallization

Materials and methods
Citrate (Tri-potassium-citrate, Sigma Chemical Co., St Louis, MO, USA) was studied at concentrations of 1.5, 2.5 and 3.5 mM by adding the double amounts of citrate to the
Spectrophotometric crystallization measurements
calcium-containing assay solution. THP was purified according to the classical procedure Freshly prepared solutions of 10.0 mM CaCl 2 (Merck, Darmstadt, Germany) and 1.0 mM K 2
, with an additional passage through a molecular sieve column (Sepharose 4-B, Pharmacia, Dü bendorf, Switzerland ), using containing 200 mM NaCl (Merck) and 10 mM sodium acetate (Merck), were adjusted to pH 5.70 (Metrohm 654 4 M urea in 0.02 M sodium phosphate, pH 6.8, as eluent [16 ] . nTHP was isolated from a 24-h urine specimen of a pH-meter, Metrohm, Herisau, Switzerland ). All chemicals were of the highest purity grade available. Before being used 31-year-old healthy male without personal or family history of kidney stone disease whose THP had been used in a in experiments, solutions were filtered through Millex-GV membranes with a pore diameter of 0.22 mm (Millipore AG, previous study of ours [16 ] . SF-THP was isolated from a 51-year-old man with a positive family history for stone Volketswil, Switzerland), and the calcium concentration was checked by measurements of ionized calcium, using an ion-disease who had formed 20 calcium stones. The three 24-h urine samples-that we routinely obtain from recurrent stone selective electrode (Ciba-Corning Diagnostics, Medfield, MA, USA). All experiments were performed at 37°C, using a formers according to our previously established protocol for metabolic evaluation [20] -were pooled for further isolation circulating water bath (Heto, Denmark). For crystallization experiments, 1.0 ml oxalate solution was transferred into a and purification of THP. By adding 0.5, 1, 1.5 and 2 mg of lyophilized protein, both THPs used in this study were run 10-mm light path quartz cuvette (Hellma No. 101, Hellma, Basle, Switzerland ) placed in a Perkin-Elmer Lambda 2 on SDS-PAGE [21] , using 4-15% gradient gels (Mini Protean II, Bio-Rad, Glattbrugg, Switzerland ) on a Mini Trans-Blot spectrophotometer (Perkin-Elmer, Ü berlingen, Germany) connected with the circulating water bath at 37°C. In the apparatus (Bio-Rad), and stained with silver stain (Bio-Rad ). cuvette, solutions were constantly stirred at 500 r.p.m. (Hellma Cuv-O-Stir Model 333), using a teflon-covered
For crystallization experiments, aqueous suspensions (2 ml ) with excess lyophilized THP were prepared and then stirring bar, size 7×2×2 mm (Semadeni, Berne, Switzerland). An additional 1.0 ml of the calcium solution centrifuged for 10 min at 4000 r.p.m. in a Heraeus Christ Biofuge A (Heraeus, Zurich, Switzerland ). Thereafter, THP layer about 400 Å thick was then sputtered onto the sample.
Specimens were investigated using a JEOL JSM-840 scanning concentration in the supernatant was measured spectrophotometrically at 277 nm [15, 16 ] . After 1.0 ml of oxalate-electron microscope with an acceleration voltage of 25 kV and a working distance between 15 and 25 mm. Photographs containing solution had been added to the cuvette, small volumes (<5 vol%) of these concentrated THP solutions were taken at magnifications of ×250, ×1000 and ×5000 respectively. were injected into the oxalate-containing solution, before the calcium-containing solution was added and the experiment On representative fields of photographs (10×13 cm) taken at 250-fold magnification during induction time as well as was started. THP was tested at concentrations of 20, 30 and 40 mg/l. during DOD max and during −DOD max , total numbers of particles were counted three times on three different days by Percentage inhibition in the presence of citrate or either form of THP was calculated as one of us (B.H.), whereby single crystals were distinguished from aggregates (defined as many crystals sticking together and forming one particle) and clusters (accumulations of [1−(S Nm /S Nc )]×100 for the rate of nucleation, many loose single crystals). In addition, maximum lengths and widths of all distinct particles on photographs [1−(S Am /S Ac )]×100 for the rate of aggregation, (10×13 cm) taken at 1000-fold magnification towards the end of −DOD max were measured, and length/width ratios respectively, where m stands for modulator and c for control were calculated.
[18]. Negative inhibition values indicate promotion of the respective crystallization process.
Statistics SEM
All values are means±SE. Unpaired and paired t-test for During induction time as well as at the end of maximum comparisons between and within groups respectively, were increase of OD 620 (DOD max , i.e. combined nucleation and used. growth) and at the end of maximum decrease of OD 620 with time (−DOD max , i.e. aggregation), 30 ml of assay solution were transferred from the spectrophotometric cuvette onto a Millipore GV filter membrane, diameter 47 mm, of pore size Results 0.22 mm (Millipore AG) under vacuum, as previously described [18] . Samples for SEM were taken from experiments under standard conditions (no modulator added ), Normal and SF-THP on SDS-PAGE with 3.5 mM citrate, with 30 mg/l of either nTHP or SF-THP, As depicted in Figure 2 , both glycoproteins migrated and with 30 mg/l of nTHP together with 3.5 mM citrate or as a single band at about 80 kDa on SDS-PAGE 30 mg/l of SF-THP together with 3.5 mM citrate. For drying, (note that proteins are overexposed at highest filters were cut to size and mounted on an aluminum holder by means of a double-sided graphitized adhesive tab. A gold concentrations). crystals by 82.1±1.0, 78.0±1.0 and 86.5±0.9% respectively, and aggregation by 62.7±1.5, 62.7±1.5 and 70.2±1.5% respectively (P=0.0001 for all comparisons between any citrate concentration and standard conditions, both for nucleation and aggregation). Figure 3 depicts findings with both forms of THP: nTHP moderately inhibited crystal nucleation only at 30 and 40 mg/l, whereas aggregation was greatly inhibited at all concentrations that we tested (P<0.005 for all concentrations vs standard conditions without nTHP). On the other hand, SF-THP did not significantly affect the rate of nucleation, whereas crystal aggregation was clearly promoted (negative inhibition values between −33 and −48%) at all concentrations of SF-THP that we studied (P<0.01 for all compar- Table 1 summarizes induction times (t I ) in presence of various crystallization modulators. Citrate at all three concentrations studied significantly prolonged t I to values between 98 and 126 s. Whereas nTHP did not affect t I , SF-THP significantly reduced it at all concentrations studied (P=0.0001 for all comparisons vs standard conditions), indicating promotion of nucleation in comparison with standard conditions. Finally, when 3.5 mM citrate was present together with either form of THP, induction time was significantly longer than with citrate alone; this indicates strong potentiation of nTHP effects and even reversal of promotory 3 summarizes particle countings on representative photographs taken at 250-fold magnification under six different experimental conditions. The decrease of total particle number due to aggregation under standard conditions (no modulator added) was totally abolished by citrate where particle number remained stable throughout the whole experiment. Whereas citrate tended to reduce particle number during DOD 620 max (P=0.056 vs standard conditions), a rise in particle number was observed during −DOD 620 max (P=0.028 vs standard conditions), indicating inhibition of crystal nucleation as well as aggregation. The same was true for nTHP: particle numbers during DOD 620 max fell in comparison with standard conditions (P=0.003), whereas they rose during −DOD 620 max (P=0.016 vs standard condi- whereas the numerous crystal aggregates found during −DOD 620 max made countings of distinct particles nucleation and aggregation by normal THP and turned impossible (see also Figures 5D and 6A) . Fewer parpromotive SF-THP into an inhibitor. ticles were nucleated during DOD 620 max , when nTHP and citrate were simultaneously present (P=0.009 vs SEM standard conditions). On the other hand, the combination of SF-THP and citrate increased the number of Figure 5 depicts representative fields of photographs at 1000-fold magnification taken at the end of experi-nucleated particles (P=0.009 vs standard conditions), whereas counting at 250-fold magnification became ments, i.e. during maximum rates of aggregation. As depicted in Table 2 , maximum length and width of impossible in samples taken during −DOD 620 max , due to cluster formation. particles under standard conditions ( Figure 5A ) amounted to 11.5±1.7 and 3.1±0.3 mm respectively, and the length/width ratio was 3.9±0.5. In the presence Discussion of 3.5 mM citrate ( Figure 5B ), the length/width ratio was highly significantly reduced due to a significant reduction in particle length. With 30 mg/l of nTHP Although results obtained with THPs from one healthy control and one severely recurrent CaOx renal stone ( Figure 5C ), there was heterogeneity of particle sizes, but a fall in the mean length/width ratio at the limit former do not allow for generalized conclusions, several important findings emerge from this in vitro study: of significance (P=0.051) was noted in comparison with standard conditions, due to a decrease in mean (i) under the experimental conditions of the present experiments, citrate is the main determinant of CaOx particle length. On the other hand, 30 mg/l of SF-THP ( Figure 5D ) tended to produce significantly longer and crystallization kinetics and crystal morphology;
(ii) nTHP is not only an inhibitor of CaOx crystal more aggregated crystals than nTHP; in comparison with standard conditions, however, particle sizes were aggregation (as previously demonstrated [12,16 ]), but-to a somewhat lesser degree-also of nucleation, not significantly affected by SF-THP. In the presence of both 3.5 mM citrate and 30 mg/l nTHP ( Figure 5E ), whereas abnormal SF-THP promotes both nucleation and aggregation of CaOx crystals; and (iii) citrate crystals were of similar shape than with citrate alone, reflected also by a similar length/width ratio; the latter reverses promotory effects of abnormal THP into inhibition of CaOx crystal nucleation and aggregation. was significantly lower than with nTHP alone. Finally, 3.5 mM citrate and 30 mg/l SF-THP ( Figure 5F ) pro-By chelation of calcium ions, citrate efficiently lowers supersaturation, the driving force for crystallization duced abundant crystals as small as with citrate alone; these crystals were often clustered, but not aggregated. [1, 22] . Citrate in a supersaturation decay system is therefore expected to reduce induction time and rate At 5000-fold magnification, Figure 6 clearly demonstrates the impact of citrate on the effects of abnormal of nucleation. In addition, citrate at the urine-like concentrations tested herein also inhibits crystal SF-THP: whereas proteinaceous material at the crystal surfaces appears to aggregate crystals like a glue aggregation. This is in apparent contradiction to our previous findings under saturated conditions [12] where ( Figure 6A) , the same experiment performed with an additional 3.5 mM of citrate produces much smaller citrate did not affect the rate of crystal aggregation.
However, whereas experiments in the present study and non-aggregated crystals ( Figure 6B) . Again, the shape of crystals in presence of citrate is clearly differ-start from a high CaOx supersaturation, our previous work was performed at permanently saturated solution ent from crystals obtained under control conditions or in presence of THP.
conditions [12, 15, 16 ] , with a calcium concentration of only 0.14 mmol/l. This was most probably too low for and aggregation [22] . Therefore, formation of significant numbers of calcium-citrate complexes may best abundant formation of calcium-citrate complexes which bind to specific sites on CaOx crystal surfaces explain crystal aggregation inhibition by citrate in the present study. and are thus crucial for lowering rates of crystal growth Numbers are crystalline particles per photographic field on photographs of 9×12 cm. All countings of particles, which were impossible in presence of SF-THP and SF-THP+ citrate, were done in triplicate. Induction time, time before crystals reach sizes/numbers which make them detectable by turbidimetry; DOD 620 max. , end of max. increase of OD 620 with time, i.e. mainly combined nucleation and growth; −DOD 620 max. , end of max. decrease of OD 620 with time, i.e. mainly aggregation. For details, see text. *P<0.05; **P<0.025; ***P<0.01; and ****P<0.005 vs standard conditions. ++P<0.01 vs DOD 620 max .
Inhibition by citrate at the urine-like concentrations their study, inhibition only became dose-dependent at citrate concentrations below 1.0 mM [23] . Obviously that we used in this in-vitro study is not concentrationdependent. This is in keeping with results previously citrate reaches its maximum effect on CaOx crystallization in vitro at millimolar, i.e. urine-like, concentra-obtained by Kok et al. [23] who, using a crystallization system very different from ours, also could not find tions. Very similar to the recent findings of Hennequin et al. [19] , our SEM studies provide evidence that dose-dependent inhibition of crystal growth and aggregation at millimolar concentrations of citrate. In citrate at millimolar concentrations has two main effects on newly forming CaOx particles in vitro, presence of citrate improves inhibitory activity of nTHP and turns promotory SF-THP into an inhibitor namely (i) precipitation of significantly smaller crystals and (ii) reduced aggregate formation. of crystallization, leading to formation of smaller and less aggregated crystals. This re-emphasizes at a mor-In accordance with our previous findings [12, 15, 16 ] , nTHP is a strong inhibitor of the aggregation of CaOx phological level what has been concluded from functional studies [16 ] as well as from a clinical point of crystals also under the highly supersaturated conditions of the present experiments. Whereas rather elongated view [26 ] , namely that citrate is needed in urine at equimolar concentrations to calcium in order to pre-CaOx crystals, similar to those described by Hennequin et al. [19, 24] , formed under standard conditions, nTHP vent the formation of large crystal aggregates in presence of abnormal THP. inhibited both nucleation and aggregation, i.e. produced fewer, smaller and less aggregated crystals. This 
